Offer - Urjas Oil for just ₹ 1
OT Dol is an allopathic medicine The correct dosage of OT Dol depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
OT Dol is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of OT Dol safe for pregnant women?
OT Dol can have harmful effects in pregnant women. If you experience any discomfort after using OT Dol, then discontinue the use and take your doctor's advice.
Is the use of OT Dol safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of OT Dol. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of OT Dol on the Kidneys?
OT Dol may have mild side effects on the kidneys.
What is the effect of OT Dol on the Liver?
OT Dol is rarely harmful for the liver.
What is the effect of OT Dol on the Heart?
OT Dol may have mild side effects on the heart. Most people will never see any effect on the heart.
OT Dol should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take OT Dol unless your doctor advises you to do so -
Is this OT Dol habit forming or addictive?
Forming a habit of OT Dol has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking OT Dol you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume OT Dol only on doctor's advice.
Is it able to treat mental disorders?
No, OT Dol is not used to treat mental disorders.
Interaction between Food and OT Dol
Taking OT Dol with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and OT Dol
Consumption of alcohol and OT Dol together may have severe effects on your health.
OT Dol is a local anesthetic agent. It should be used strictly under the recommendation of a doctor. You must use it for as long as it has been prescribed by your doctor.
Yes, OT Dol may cause an allergic reaction which might manifest as sneezing, wheezing, pruritis (severe itching of the skin), urticaria (localized swollen itchy area), episodes of angioneurotic edema (swelling of the lower layer of skin or mucous membranes and even anaphylactic shock (very severe allergic reaction). If you develop any of these symptoms while using OT Dol, please inform your doctor immediately.
According to an FDA warning published in 2014, a 2% solution of OT Dol should not be used in infants and young children (5 months to 3.5 years old), as too much application of OT Dol or accidental swallowing may cause serious brain injury, seizures, and heart problems. Therefore, for treating teething pain, one must take the advice of their doctor and follow his recommendations completely.
Yes, OT Dol may cause drowsiness or sleepiness. It is a common side effect of this drug. Activities such as driving and operating heavy machinery should be avoided after taking this OT Dol to prevent accidents and injuries as it causes drowsiness.
Yes, OT Dol is used topically for producing an anesthetic effect (Prevent pain) on the irritated or inflamed mucous membranes of mouth and pharynx. It is also used for minimizing gagging during X-ray procedure and dental impressions.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Qvar® Redihaler™ (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-356
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; QVAR® (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
